or
forgot password
  • cancer clinical trials in hackensack, NJ

  • Treatment for Acute Graft-Versus-Host Disease
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Graft vs Host Disease, Immune System Disorders
    Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Bladder Cancer
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    David Center for Childrens Pain and Palliative Care
    Hackensack, New Jersey 07601
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
    The Cancer Center Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Myeloma
    A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes

    Hackensack, New Jersey 07601
    Myelodysplastic Syndrome
    Trial of Decitabine in Patients With Acute Myeloid Leukemia

    Hackensack, New Jersey 07601
    Acute Myeloid Leukemia
    A Long-term Safety Study of Infliximab (Remicade)

    Hackensack, New Jersey 07601
    Arthritis, Rheumatoid, Crohn Disease, Psoriasis
    Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
    Hackensack University Medical Center # 408
    Hackensack, New Jersey 07601
    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Chronic Myeloid Leukemia
    Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Childhood Rhabdomyosarcoma, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Neuroblastoma
    A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Acute Myelogenous Leukemia
    A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
    Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Oral Mucositis, Stomatitis
    Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Multiple Myeloma and Plasma Cell Neoplasm
    A Study of SB-743921 in Non-Hodgkin's Lymphoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Non-Hodgkin's Lymphoma, Hodgkin's Disease
    A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
    Site Ref # / Investigator 3565
    Hackensack, New Jersey 07601
    Lung Cancer, Non-Small Cell Lung Cancer
    A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Hepatocellular Carcinoma (HCC)
    Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Peripheral T-cell Lymphoma
    Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Graft Versus Host Disease
    Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Kidney Cancer, Leukemia, Lymphoma, Neurotoxicity, Peripheral Neuropathy, Sarcoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Bladder Cancer, Transitional Cell Carcinoma, Metastasis
    AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Autologous Stem Cell Transplantation
    TroVax Renal Immunotherapy Survival Trial
    The Cancer Center @ HUMC
    Hackensack, New Jersey 07601
    Clear Cell Renal Carcinoma
    A Study of R547 in Patients With Advanced Solid Tumors.

    Hackensack, New Jersey 07601
    Neoplasms
    Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Cytomegalovirus Infections
    Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
    Hackensack University Medical Center, Obstetrics and Gynecology Oncology
    Hackensack, New Jersey 07601
    Ovarian Cancer
    Phase I/II Study of hLL1 in Multiple Myeloma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA
    Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Lymphoma, Follicular
    Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Lung Cancer
    Registration and Informed Consent Study for the Childhood Cancer Research Network
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Unspecified Childhood Solid Tumor, Protocol Specific
    Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma
    Hackensack University
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
    Hackensack University Medical Center at the Cancer Center
    Hackensack, New Jersey 07601
    B-lymphoid Malignancies, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Multiple Myeloma
    High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Melanoma (Skin)
    Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)
    Hackensack University Medical Center/Oncology Research Dept.
    Hackensack, New Jersey 07601
    Leukemia, Myeloid, Chronic
    Lived Experiences of Adolescents in the Treatment Process of Cancer and the Impact on Occupations
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Pediatric Cancer
    A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Sarcoma
    A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Diffuse Large B-cell Lymphoma
    The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
    Hackensack Univeristy Medical Center
    Hackensack, New Jersey 07601
    Breast Cancer
    Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia
    A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Renal Cell Carcinoma
    Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma
    Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Acute Lymphoblastic Leukemia (ALL)
    Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
    Hackensack University Medical Ctr
    Hackensack, New Jersey 07601
    Cutaneous T-cell Lymphoma (CTCL),
    Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Myelogenous Leukemia
    Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Multiple Myeloma
    Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
    Hackensack University Medical Center Cancer Center
    Hackensack, New Jersey 07601
    Leukemia
    Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer
    The Cancer Center at Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Breast Neoplasms
    GAUSS: A Study of RO5072759 in Patients With Indolent Non-Hodgkin's Lymphoma

    Hackensack, New Jersey 07601
    Non-Hodgkin's Lymphoma
    A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Non Small Cell Lung Cancer
    Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

    Hackensack, New Jersey 07601
    Carcinoma, Renal Cell
    A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

    Hackensack, New Jersey 07601
    Hematologic Neoplasms
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840009
    Hackensack, New Jersey 07601
    Urinary Bladder Neoplasms
    RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Upper Respiratory Tract Infection, Lower Respiratory Tract Infection
    Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze
    Hackensack University Medical Center
    Hackensack, New Jersey 07601
    Osteosarcoma, Leukemia, Lymphoma